SCHEMBL4759707

SCHEMBL4759707

Cc1cc(NC(=O)O)ccc1-c1nc(C(N)CC2CCC(=O)CC2)[nH]c1Cl

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
SLC1A1 P43005 2/20 0.36
F11 P03951 7/20 0.35
AAK1 Q2M2I8 3/20 0.33
CIT O14578 2/20 0.33
ROCK2 O75116 3/20 0.33
ROCK1 Q13464 1/20 0.32
KLKB1 P03952 1/20 0.32
HIPK4 Q8NE63 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
BMP2K Q9NSY1 1/20 0.32
FASN P49327 1/20 0.32
JAK1 P23458 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4759749 0.83 AAK1 (0.38) F11AAK1KLKB1
SCHEMBL1196771 0.78 F11 (0.49) F11KLKB1
SCHEMBL1197488 0.71 F11 (0.50) F11KLKB1
SCHEMBL1197235 0.63 F11 (0.46) F11AAK1KLKB1
SCHEMBL1197231 0.63 F11 (0.46) F11AAK1KLKB1
SCHEMBL15880444 0.59 ROCK1 (0.69) ROCK2ROCK1
SCHEMBL1196478 0.59 F11 (0.52) F11KLKB1
SCHEMBL1197057 0.57 F11 (0.63) F11ROCK2KLKB1
SCHEMBL1197333 0.57 F11 (0.63) F11ROCK2KLKB1
SCHEMBL2093174 0.56 NPC1 (0.59) LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981854-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS Brystol-Myers Squibb Company (US) 2008-10-22 EP disclosed
WO-2007070826-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed